vTv reports Alzheimer’s candidate failure
It is looking likely that another late-stage candidate for Alzheimer’s disease will fail to make it past Phase III trials, with vTv Therapeutics’ experimental therapy the latest in a long line to miss its targets. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/vtv_reports_alzheimers_candidate_failure_1231331